Muriel Noetzli

Population pharmacokinetic approach to evaluate the effect of <i><scp>CYP2D6</scp>, <scp>CYP3A</scp>, <scp>ABCB1</scp>, <scp>POR</scp></i> and <i><scp>NR1I2</scp></i> genotypes on donepezil clearance

Muriel Noetzli, Monia Guidi, Karsten Ebbing et al. · British Journal of Clinical Pharmacology · 2014 · 51 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Simultaneous determination of antidementia drugs in human plasma: Procedure transfer from HPLC–MS to UPLC–MS/MS

Muriel Noetzli, Nicolas Ansermot, Maria Dobrinas et al. · Journal of Pharmaceutical and Biomedical Analysis · 2012 · 51 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +13

Population Pharmacokinetic Study of Memantine: Effects of Clinical and Genetic Factors

Muriel Noetzli, Monia Guidi, Karsten Ebbing et al. · Clinical Pharmacokinetics · 2013 · 42 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Quantification of nicotine, cotinine, trans-3′-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC–tandem mass-spectrometry procedure for a clinical study on smoking cessation

Maria Dobrinas, Eva Choong, Muriel Noetzli et al. · Journal of Chromatography B · 2011 · 42 citations

Pharmacy, Pharmacology, Toxicology +11

Relationship of CYP2D6, CYP3A, POR, and ABCB1 Genotypes With Galantamine Plasma Concentrations

Muriel Noetzli, Monia Guidi, Karsten Ebbing et al. · Therapeutic Drug Monitoring · 2013 · 30 citations

Pharmacy, Pharmacokinetics, Pharmacology +17